Comparison of 2D and 3D fast non-local means in pediatric abdominal low-dose computed tomographic image.

Publication date: Jul 21, 2026

Fast non-local means (FNLM) is a post-processing technique that suppresses noise while preserving edges. FNLM can be implemented in two-dimensional (2D) and three-dimensional (3D) forms, yet the effect of smoothing factor selection on performance in pediatric low-dose computed tomography (CT) remains unclear. This study applied 2D and 3D FNLM to 30 pediatric abdominal CT cases with simulated low-dose noise using smoothing factors from 0. 001 to 0. 060. Image quality was evaluated using the coefficient of variation (COV), peak signal-to-noise ratio (PSNR), and structural similarity index measure (SSIM). In both algorithms, COV decreased markedly as the smoothing factor increased, particularly from 0. 001 to 0. 016, whereas PSNR and SSIM showed relatively limited variation. SSIM reached the maximum value at 0. 016, followed by a gradual decrease. Linear mixed-effects models demonstrated significant effects of the smoothing factor on all metrics. Wilcoxon signed-rank test indicated significantly lower COV and higher SSIM with 3D FNLM while PSNR showed no significant difference. 3D FNLM provided significant improvements in noise uniformity and structural preservation with modest effects. In contrast, 2D FNLM remains a practical option when computational efficiency takes priority. Overall, a smoothing factor around 0. 016 offers a favorable balance between noise reduction and structural fidelity.

Open Access PDF

Concepts Keywords
Algorithms Fast non-local means
Decreased Noise reduction
Fast Quantitative metrics
Pediatric Structural preservation
Tomography

Semantics

Type Source Name
disease MESH image
drug DRUGBANK Isoxaflutole
disease MESH Park
pathway REACTOME Reproduction
disease MESH included
disease MESH Park1
disease MESH acute abdomen
disease MESH liver disease
disease MESH liver failure
disease MESH hepatomegaly
disease MESH liver abscesses
disease MESH hemorrhage
disease MESH malignancy
drug DRUGBANK Methyldopa
drug DRUGBANK Resiniferatoxin
drug DRUGBANK Sulodexide
disease MESH PBC
disease MESH emergency
disease MESH acute liver failure
disease MESH liver neoplasms
disease MESH abdominal pain
disease MESH trauma
drug DRUGBANK Nonoxynol-9
disease MESH Acute Renal Colic
drug DRUGBANK Guanosine
disease MESH emphysema
drug DRUGBANK Tricyclazole
drug DRUGBANK (S)-Des-Me-Ampa

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *